Response to Goodwin et al.

Australian veterinary journal(2023)

引用 0|浏览2
暂无评分
摘要
Australian Veterinary JournalEarly View LETTER TO THE EDITOR Response to Goodwin et al. MK Wun, Corresponding Author MK Wun [email protected] Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, Washington State, USA Corresponding author. Matthew K. Wun, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-7060, USA; [email protected]Search for more papers by this authorR Malik, R Malik Centre for Veterinary Education, B22, The University of Sydney, Sydney, New South Wales, AustraliaSearch for more papers by this author MK Wun, Corresponding Author MK Wun [email protected] Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, Washington State, USA Corresponding author. Matthew K. Wun, Department of Veterinary Clinical Sciences, College of Veterinary Medicine, Washington State University, Pullman, WA 99164-7060, USA; [email protected]Search for more papers by this authorR Malik, R Malik Centre for Veterinary Education, B22, The University of Sydney, Sydney, New South Wales, AustraliaSearch for more papers by this author First published: 17 August 2023 https://doi.org/10.1111/avj.13283Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1Wun MK, Leister E, King T et al. Acute kidney injury in 18 cats after subcutaneous meloxicam and an update on non-steroidal anti-inflammatory drug usage in feline patients in Australia. Aust Vet J 2023; 101: 90–98. 2Goodwin W, Monteiro BP, Grimm K et al. Letter to the editor. Aust Vet J XXXXXX (please fill in). 3Härmark L, van Grootheest AC. Pharmacovigilance: methods, recent developments and future perspectives. Eur J Clin Pharmacol 2008; 64: 743–752. 4 Metacam anti-inflammatory injectable for dogs and cats, Boehringer Ingelheim Animal Health Australia Pty. Ltd, Label no. 135228, Australian Pesticides and Veterinary Medicines Authority, 2022-07-20. 5Munoz-Rubke F, Olson D, Will R et al. Functional fixedness in tool use: learning modality, limitations and individual differences. Acta Psychol 2018; 190: 11–26. 6Steagall PV, Robertson S, Simon B et al. 2022 ISFM consensus guidelines on the management of acute pain in cats. J Feline Med Surg 2022; 24: 4–30. 7Daly AK. Pharmacogenetics: a general review on progress to date. Br Med Bull 2017; 124(1): 65–79. 8Martinez SE, Andresen MC, Zhu Z et al. Pharmacogenomics of poor drug metabolism in greyhounds: cytochrome P450 (CYP) 2B11 genetic variation, breed distribution, and functional characterization. Sci Rep 2020; 10: 69. 9Rodriguez DB, Mackin A, Easley R et al. Relationship between red blood cell thiopurine methyltransferase activity and myelotoxicity in dogs receiving azathioprine. J Vet Intern Med 2004; 18(3): 339–345. 10Belay ED, Bresee JS, Holman RC et al. Reye's syndrome in the United States from 1981 through 1997. New Eng J Med 1999; 340(18): 1377–1382. 11Fisher MM. Severe histamine mediated reactions to Althesin. Anaesth Intensive Care 1976; 4(1): 33–35. 12Whittem T, Pasloske KS, Heit MC et al. The pharmacokinetics and pharmacodynamics of alfaxalone in cats after single and multiple intravenous administration of Alfaxan® at clinical and supraclinical doses. J Vet Pharmacol Therap 2008; 31(6): 571–579. 13Wolman B. Fatal aplastic anaemia after chloramphenicol. Brit Med J 1952; 2(4781): 423–426. 14Gunew MN, Menrath VH. Marshall RD long-term safety, efficacy and palatability of oral meloxicam at 0.01–0.03 mg/kg for treatment of osteoarthritic pain in cats. J Feline Med Surg 2008; 10(3): 235–241. Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation
更多
查看译文
关键词
response,al
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要